https://pubmed.ncbi.nlm.nih.gov/34046462/ PFIC

Case Reports

World J Clin Cases. 2021 May 26;9(15):3631-3636.
doi: 10.12998/wjcc.v9.i15.3631.

Progressive familial intrahepatic cholestasis - farnesoid X receptor deficiency due to NR1H4mutation: A case report

Piotr Czubkowski 1, Richard J Thompson 2, Irena Jankowska 3, A S Knisely 4, Milton Finegold 5, Pamela Parsons 5, Joanna Cielecka-Kuszyk 6, Sandra Strautnieks 2, Joanna Pawłowska 3, Laura N Bull 7

Abstract

Background: Functioning farnesoid X receptor (FXR; encoded by NR1H4) is key to normal bile acid homeostasis. Biallelic mutations in NR1H4 are reported in a few children with intrahepatic cholestasis. We describe a boy with progressive familial intrahepatic cholestasis and homozygous mutation in NR1H4.

Case summary: A boy had severe neonatal cholestasis with moderate hypercholanemia and persistently elevated alpha-fetoprotein. Despite medical treatment, coagulopathy was uncontrollable, prompting liver transplantation at age 8 mo with incidental splenectomy. The patient experienced catch-up growth with good liver function and did not develop allograft steatosis. However, 1 year after transplant, he died from an acute infection, considered secondary to immunosuppression and asplenia. A homozygous protein-truncating mutation, c.547C > T, p.(Arg183Ter), was subsequently identified in NR1H4, and both parents were shown to be heterozygous carriers. Absence of FXR and of bile salt export pump expression was confirmed by immunostaining of explanted liver.

Conclusion: Severe cholestasis with persistently high alpha-fetoprotein and modest elevation of serum bile acid levels may suggest FXR deficiency. Some patients with FXR deficiency may not develop allograft steatosis and may respond well to liver transplantation.